Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Northwest Biotherapeutics (NWBO) Share-based Compensation (IS) (2009 - 2019)

Updated

Analysis

Northwest Biotherapeutics (NWBO) Share-based Compensation (IS) (2009 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Northwest Biotherapeutics 283.78 Mn 273.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 10.68 Mn
Sep 30, 2010 492,000.00
Jun 30, 2010 506,000.00
Sep 30, 2009 468,000.00
Jun 30, 2009 468,000.00
API Access

Northwest Biotherapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=NWBO&period=max&api_key=YOUR_API_KEY